Literature DB >> 32497997

Lifting the fog of confusion about breast cancer screening guidelines: Surprise - it's about the money!

Daniel B Kopans1.   

Abstract

Large amounts of misinformation denigrating the benefits of breast cancer screening have been published over the past 50 years and continue to be published. Each effort to reduce breast cancer screening has been refuted, scientifically, but the efforts continue. The motivation has been unclear until the recent guidelines issued by the American Society of Breast Surgeons who support annual screening starting at the age of 40 contrasted with the American College of Physicians who advocated delaying screening until the age of 50 and then biennially. An analysis of the facts can only lead to the conclusion that delayed screening has been chosen to save money rather than lives.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32497997     DOI: 10.1016/j.clinimag.2020.03.009

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  1 in total

1.  Atypical Hyperplasia Found Incidentally during Routine Breast Reduction Mammoplasty: Incidence and Management.

Authors:  Seth Noorbakhsh; Zachary A Koenig; Noah Hewitt; Mihail Climov; Hannah Hazard-Jenkins; Melina Flanagan; Kerri Woodberry
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-02-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.